Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial
| Autor: | Daubert, C, Gold, MR, Abraham, WT, Ghio, S, Hassager, C, Goode, G, Szili-Torok, T (Tamás), Linde, C |
|---|---|
| Přispěvatelé: | Service de cardiologie et maladies vasculaires, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Division of cardiology, Medical University of South Carolina [Charleston] (MUSC), Fondazione IRCCS Policlinico San Matteo [Pavia], Università di Pavia, Rigshospitalet [Copenhagen], Copenhagen University Hospital, Department of Cardiology, Karolinska University Hospital, Karolinska Institutet [Stockholm], REVERSE Study Group, Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes], Cardiology |
| Jazyk: | angličtina |
| Rok vydání: | 2009 |
| Předmět: |
genetic structures
cardiac resynchronization therapy heart failure MESH: Cardiac Pacing Artificial MESH: Ventricular Remodeling MESH: Hospitalization MESH: Defibrillators Implantable [INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system MESH: Ventricular Dysfunction Left cardiovascular diseases MESH: Treatment Outcome MESH: Aged MESH: Middle Aged MESH: Humans reverse cardiac remodeling MESH: Follow-Up Studies MESH: Male MESH: Prospective Studies randomized controlled trial MESH: Heart Failure cardiovascular system biventricular stimulation MESH: Disease Progression [SDV.IB]Life Sciences [q-bio]/Bioengineering MESH: Europe MESH: Female [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing |
| Zdroj: | Journal of the American College of Cardiology Journal of the American College of Cardiology, Elsevier, 2009, 54 (20), pp.1837-46. ⟨10.1016/j.jacc.2009.08.011⟩ Journal of the American College of Cardiology, 54(20), 1837-1846. Elsevier Inc. |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/j.jacc.2009.08.011⟩ |
| Popis: | Objectives The aim of this study was to determine the long-term effects of cardiac resynchronization therapy (CRT) in the European cohort of patients enrolled in the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Background Previous data suggest that CRT slows disease progression and improves the outcomes of asymptomatic or mildly symptomatic patients with left ventricular (LV) dysfunction and a wide QRS complex. Methods We randomly assigned 262 recipients of CRT pacemakers or defibrillators, with QRS >= 120 ms and LV ejection fraction |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|